WuXi Biologics (Cayman) Inc. (2269) announced that its Board of Directors will convene on March 24, 2026. The purpose of this meeting is to consider and approve the annual results for the year ended December 31, 2025, as well as to address other related matters.
According to the announcement dated February 11, 2026, the Board currently comprises executive, non-executive, and independent non-executive directors, with Dr. Ge Li serving as Chairman.